The gluten-free diet has proven to be an effective treatment for celiac disease, but there are many challenges in adopting and maintaining a gluten-free diet that can impact a person’s quality of life and long-term health outcomes. Patients, doctors and researchers agree that there is a great need for alternative treatments that could replace or supplement the gluten-free diet.
This section will share information and updates about the drug discovery and development processes. Learn about the latest from pharmaceutical and biotech companies, as well as how you can get involved in clinical trials that will advance celiac disease research.
Sign Up to Receive Research News and Announcements through
the Beyond Celiac Research Opt-In
Research in the area of celiac disease and other gluten-related disorders advances every day. From online surveys to clinical trials, there are many opportunities to get involved and help researchers move closer to increased diagnoses, improved disease management tools, new pharmaceutical treatments and even a cure for celiac disease. Patient participation in research is key to ensuring that the field continues to advance. Sign up for the Beyond Celiac Research Opt-In today to learn more about opportunities to participate in research.
|Sign up: The Beyond Celiac Research Opt-In|
“Celiac Disease: Immunology 101 and the Drug Development Process ”
Do you know how celiac disease works? Download this 1-hour webinar presented by Beyond Celiac, featuring two experts in immunology and pharmacology. Additional resources include a Q&A with celiac disease expert Joseph Murray, MD, on potential therapies that could be used to treat celiac disease in the future.
|Free Webinar: Celiac Disease Immunology 101 and the Drug Development Process|
Find the latest information about celiac disease drugs being studied, how they would work and how far they are in the clinical trial process with our drug pipeline.
Beyond Celiac has a bold plan for a better future. Having revised its vision and mission in Spring of 2017, the organization announced its plan and has set its sights on conquering the disease all together.